| Autor: |
Vernooij, Robin W M, Hockham, Carinna, Strippoli, Giovanni, Green, Suetonia, Hegbrant, Jörgen, Davenport, Andrew, Barth, Claudia, Canaud, Bernard, Woodward, Mark, Blankestijn, Peter J, Bots, Michiel L, Blankestijn, Peter J, Vernooij, Robin WM, Hockham, Carinna, Strippoli, Giovanni FM, Canaud, Bernard, Hegbrant, Jörgen, Barth, Claudia, Cromm, Krister, Davenport, Andrew, Rose, Matthias, Török, Marietta, Woodward, Mark, Bots, Michiel, Blankestijn, Peter J, Bots, Michiel L, Canaud, Bernard, Davenport, Andrew, Grooteman, Muriel PC, Kircelli, Fatih, Locatelli, Franco, Maduell, Francisco, Morena, Marion, Nubé, Menso J, Ok, Ercan, Torres, Ferran, Woodward, Mark |
| Zdroj: |
The Lancet; November 2024, Vol. 404 Issue: 10464 p1742-1749, 8p |
| Abstrakt: |
High-dose haemodiafiltration has been shown, in a randomised clinical trial, to result in a 23% lower risk of mortality for patients with kidney failure when compared with conventional high-flux haemodialysis. Nevertheless, whether treatment effects differ across subgroups, whether a dose–response relationship with convection volume exists, and the effects on cause-specific mortality remain unclear. The aim of this individual patient data meta-analysis was to compare the effects of haemodiafiltration and standard haemodialysis on all-cause and cause-specific mortality. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
